Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevention of postpartum hemorrhage with methylergonovine, oxytocin, or sublingual prostaglandin
IRCT201106143756N2Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Nov 2010
- Modality
- Recombinant Proteins and Enzymes, Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of methylergometrine and oxytocin in postpartum hemorrhage (PPH) (3 arms), sponsored by Ahvaz Jundishapur University of Medical Sciences. Started Nov 2010; status: completed.
02
Drugs
methylergometrineoxytocin
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on IRCT201106143756N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201106143756N2.